Skip to content

Natera, Inc.

NTRA· NasdaqCore metricsCIK 1604821

Medical laboratories28 peers

Last sale
Nov 12, 2026 · +0.98%
Market cap
$46.81B
145M shares
Filings
1,167
$793.98M
Q3 2026+35.9% FY25 yoy
-$59.91M
Q3 2026N/M FY25 yoy
-$68.32M
Q3 2026N/M FY25 yoy
$14.65M
Q3 2026derived+57.6% FY25 yoy
-$0.42
Q3 2026N/M FY25 yoy
$1.10B
Q3 2026+13.8% FY25 yoy
$46.81B
—
16.1×
25.0×
0.11%
—

Twelve months to Sep 30, 2026 · derived

Price

$322.85+56.14%+$116.08past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$2.31BFY 2025
$2.31B0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$2,306,113,000reported
FY 20242024-12-31$1,696,911,000reported
FY 20232023-12-31$1,082,571,000reported
FY 20222022-12-31$820,222,000reported
FY 20212021-12-31$625,486,000reported
FY 20202020-12-31$391,005,000reported
FY 20192019-12-31$302,328,000reported
FY 20182018-12-31$257,654,000reported
FY 20172017-12-31$209,625,000 revisedreported
FY 20162016-12-31$212,512,000 revisedreported
FY 20152015-12-31$190,355,000reported
FY 20142014-12-31$159,289,000reported

Segments

Revenue by Geography, FY2018 to FY2025FY2018United States · FY2018 · $225.93MEurope, Middle East, India, and Africa · FY2018 · $20.87MAmericas, excluding U.S. · FY2018 · $3.47MAsia Pacific and Other · FY2018 · $7.39MFY2019United States · FY2019 · $260.85MEurope, Middle East, India, and Africa · FY2019 · $15.43MAmericas, excluding U.S. · FY2019 · $3.22MAsia Pacific and Other · FY2019 · $22.83MFY2020United States · FY2020 · $365.66MEurope, Middle East, India, and Africa · FY2020 · $14.33MAmericas, excluding U.S. · FY2020 · $3.47MAsia Pacific and Other · FY2020 · $7.54MFY2021United States · FY2021 · $590.87MEurope, Middle East, India, and Africa · FY2021 · $20.43MAmericas, excluding U.S. · FY2021 · $4.05MAsia Pacific and Other · FY2021 · $10.14MFY2022United States · FY2022 · $785.85MEurope, Middle East, India, and Africa · FY2022 · $16.64MAmericas, excluding U.S. · FY2022 · $3.71MAsia Pacific and Other · FY2022 · $14.03MFY2023United States · FY2023 · $1.05BEurope, Middle East, India, and Africa · FY2023 · $22.81MAmericas, excluding U.S. · FY2023 · $4.91MAsia Pacific and Other · FY2023 · $7.22MFY2024United States · FY2024 · $1.66BEurope, Middle East, India, and Africa · FY2024 · $23.88MAmericas, excluding U.S. · FY2024 · $6.62MAsia Pacific and Other · FY2024 · $8.66MFY2025United States · FY2025 · $2.26BEurope, Middle East, India, and Africa · FY2025 · $24.48MAmericas, excluding U.S. · FY2025 · $9.35MAsia Pacific and Other · FY2025 · $8.01M
LineFY2025ShareChange
United States$2.26B98%+36.6%
Europe, Middle East, India, and Africa$24.48M1.1%+2.5%
Americas, excluding U.S.$9.35M0.4%+41.3%
Asia Pacific and Other$8.01M0.3%−7.5%
Total$2.31B

From the 10-K filed Feb 27, 2026NTRA

Medical laboratories

Natera, Inc. is the 4th largest of the 29 covered companies the SEC files under this code, by revenue. SIC 8071

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Natera, Inc. · CIK 1604821 · Engraved from SEC EDGAR